openPR Logo
Press release

H2 2017 Telomerase Reverse Transcriptase Pipeline Review

H2 2017 Telomerase Reverse Transcriptase Pipeline Review

"The Report Telomerase Reverse Transcriptase (HEST2 or Telomerase Catalytic Subunit or Telomerase Associated Protein 2 or TERT or EC 2.7.7.49) - Pipeline Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"

According to the recently published report 'Telomerase Reverse Transcriptase - Telomerase Reverse Transcriptase'; Telomerase Reverse Transcriptase (HEST2 or Telomerase Catalytic Subunit or Telomerase Associated Protein 2 or TERT or EC 2.7.7.49) pipeline Target constitutes close to 31 molecules. Out of which approximately 25 molecules are developed by companies and remaining by the universities/institutes.

Telomerase Reverse Transcriptase (HEST2 or Telomerase Catalytic Subunit or Telomerase Associated Protein 2 or TERT or EC 2.7.7.49) - Telomerase reverse transcriptase is a catalytic subunit of the enzyme telomerase. Telomerase activity is regulated by a number of factors including telomerase complex-associated proteins, chaperones and polypeptide modifiers. It modulates Wnt signaling. It plays important role in aging and anti-apoptosis.

The report 'Telomerase Reverse Transcriptase - Telomerase Reverse Transcriptase' outlays comprehensive information on the Telomerase Reverse Transcriptase (HEST2 or Telomerase Catalytic Subunit or Telomerase Associated Protein 2 or TERT or EC 2.7.7.49) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type; that are being developed by Companies / Universities.

Get Sample Copy Of This Report @
https://www.marketresearchreports.biz/sample/sample/1343234

It also reviews key players involved in Telomerase Reverse Transcriptase (HEST2 or Telomerase Catalytic Subunit or Telomerase Associated Protein 2 or TERT or EC 2.7.7.49) targeted therapeutics development with respective active and dormant or discontinued projects. Currently, The molecules developed by companies in Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical and Discovery stages are 2, 8, 2, 1, 8 and 4 respectively. Similarly, the universities portfolio in Phase I, Preclinical and Discovery stages comprises 2, 3 and 1 molecules, respectively. Report covers products from therapy areas Oncology, Central Nervous System, Cardiovascular, Hematological Disorders, Immunology, Male Health and Metabolic Disorders which include indications Non-Small Cell Lung Cancer, Breast Cancer, Prostate Cancer, Solid Tumor, Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia), Alzheimer's Disease, Hepatocellular Carcinoma, Chronic Lymphocytic Leukemia (CLL), Colorectal Cancer, Gastric Cancer, Glioblastoma Multiforme (GBM), Lung Cancer, Ovarian Cancer, Pancreatic Cancer, Amyotrophic Lateral Sclerosis, Aplastic Anemia, Atherosclerosis, Benign Prostatic Hyperplasia, Bile Duct Cancer (Cholangiocarcinoma), Blood Cancer, Cervical Cancer, Gastroesophageal (GE) Junction Carcinomas, Graft Versus Host Disease (GVHD), Head And Neck Cancer Squamous Cell Carcinoma, Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer, Hormone-Sensitive Prostate Cancer, Leukemias, Metastatic Brain Tumor, Metastatic Melanoma, Metastatic Renal Cell Carcinoma, Metastatic Transitional (Urothelial) Tract Cancer, Muscle Invasive Bladder Cancer (MIBC), Myelodysplastic Syndrome, Myelofibrosis, Non-Hodgkin Lymphoma, Non-Small Cell Lung Carcinoma, Pancreatic Ductal Adenocarcinoma, Premature Ageing and Renal Cell Carcinoma.

View Report @ https://www.marketresearchreports.biz/reports/1343234/telomerase-reverse-transcriptase-hest2-or-telomerase-catalytic-subunit-or-telomerase-associated-protein-2-or-tert-or-ec-27749-pipeline-review-h2-2017-market-research-reports

Scope

- The report provides a snapshot of the global therapeutic landscape for Telomerase Reverse Transcriptase (HEST2 or Telomerase Catalytic Subunit or Telomerase Associated Protein 2 or TERT or EC 2.7.7.49)
- The report reviews Telomerase Reverse Transcriptase (HEST2 or Telomerase Catalytic Subunit or Telomerase Associated Protein 2 or TERT or EC 2.7.7.49) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in Telomerase Reverse Transcriptase (HEST2 or Telomerase Catalytic Subunit or Telomerase Associated Protein 2 or TERT or EC 2.7.7.49) targeted therapeutics and enlists all their major and minor projects
- The report assesses Telomerase Reverse Transcriptase (HEST2 or Telomerase Catalytic Subunit or Telomerase Associated Protein 2 or TERT or EC 2.7.7.49) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news and deals related to Telomerase Reverse Transcriptase (HEST2 or Telomerase Catalytic Subunit or Telomerase Associated Protein 2 or TERT or EC 2.7.7.49) targeted therapeutics

Send An Enquiry Request @
https://www.marketresearchreports.biz/sample/enquiry/1343234

Reasons to buy

- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand the targeted therapy areas and indications for Telomerase Reverse Transcriptase (HEST2 or Telomerase Catalytic Subunit or Telomerase Associated Protein 2 or TERT or EC 2.7.7.49)
- Identify the use of drugs for target identification and drug repurposing
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Telomerase Reverse Transcriptase (HEST2 or Telomerase Catalytic Subunit or Telomerase Associated Protein 2 or TERT or EC 2.7.7.49) development landscape
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents
Table of Contents 2
List of Tables 7
List of Figures 7
Introduction 8
Global Markets Direct Report Coverage 8
Telomerase Reverse Transcriptase (HEST2 or Telomerase Catalytic Subunit or Telomerase Associated Protein 2 or TERT or EC 2.7.7.49) - Overview 9
Telomerase Reverse Transcriptase (HEST2 or Telomerase Catalytic Subunit or Telomerase Associated Protein 2 or TERT or EC 2.7.7.49) - Therapeutics Development 10
Products under Development by Stage of Development 10
Products under Development by Therapy Area 11
Products under Development by Indication 12
Products under Development by Companies 15
Products under Development by Universities/Institutes 20
Telomerase Reverse Transcriptase (HEST2 or Telomerase Catalytic Subunit or Telomerase Associated Protein 2 or TERT or EC 2.7.7.49) - Therapeutics Assessment 22
Assessment by Mechanism of Action 22
Assessment by Route of Administration 24
Assessment by Molecule Type 26
Telomerase Reverse Transcriptase (HEST2 or Telomerase Catalytic Subunit or Telomerase Associated Protein 2 or TERT or EC 2.7.7.49) - Companies Involved in Therapeutics Development 28
Argos Therapeutics Inc 28
Asterias Biotherapeutics Inc 28
e-Therapeutics Plc 29
F. Hoffmann-La Roche Ltd 29
Inovio Pharmaceuticals Inc 30
Invectys SA 30
Johnson & Johnson 31
Komipharm International Co Ltd 31
Mediolanum farmaceutici SpA 32
Telocyte LLC 32
TILT Biotherapeutics Ltd 33
Ultimovacs AS 33
Vaxon Biotech 33
Telomerase Reverse Transcriptase (HEST2 or Telomerase Catalytic Subunit or Telomerase Associated Protein 2 or TERT or EC 2.7.7.49) - Drug Profiles 35
AGS-499 - Drug Profile 35
Product Description 35
Mechanism Of Action 35

About us

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Mr. Nachiket
State Tower
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074
Website: http://www.marketresearchreports.biz/
Email: sales@marketresearchreports.biz

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release H2 2017 Telomerase Reverse Transcriptase Pipeline Review here

News-ID: 770774 • Views: 527

More Releases from MarketResearchReports.biz

Global Automotive Augmented Reality and Virtual Reality Market Breakdown Data by …
MarketResearchReports.Biz has recently announced the Latest industry research report on: “Global Automotive Augmented Reality and Virtual Reality Market Insights, Forecast to 2025” Augmented reality (AR) is a technology that adds on or layers digital media, such as touch feedback, graphics, 3D models, and sound, on a real world environment to enhance user experience and interaction. Virtual reality (VR) is a computer simulated reality that is achieved through replicating an environment
Global Artificial Intelligence in Transportation Market Breakdown Data by Region …
MarketResearchReports.Biz has recently announced the Latest industry research report on: “Global Artificial Intelligence in Transportation Market Insights, Forecast to 2025” Global Artificial Intelligence in Transportation market size will reach million US$ by 2025, from million US$ in 2017, at a CAGR of during the forecast period. In this study, 2017 has been considered as the base year and 2018-2025 as the forecast period to estimate the market size for Artificial
Global Automotive Wind Tunnel Testing Equipment Market Forecast to 2025: By Prod …
MarketResearchReports.Biz has recently announced the Latest industry research report on: “Global Automotive Wind Tunnel Testing Equipment Market Insights, Forecast to 2025” Global Automotive Wind Tunnel Testing Equipment market size will reach million US$ by 2025, from million US$ in 2017, at a CAGR of during the forecast period. In this study, 2017 has been considered as the base year and 2018-2025 as the forecast period to estimate the market size
Global Automotive Beauty Industry Analysis and Forecast 2018-2025
MarketResearchReports.Biz has recently announced the Latest industry research report on: “Global Automotive Beauty Market Insights, Forecast to 2025” This industry study presents the global Automotive Beauty market size, historical breakdown data (2013-2018) and forecast (2018-2025). The Automotive Beauty production, revenue and market share by manufacturers, key regions and type; The consumption of Automotive Beauty in volume terms are also provided for major countries (or regions), and for each application and product

All 5 Releases


More Releases for Telomerase

Global Mitomycin C Market: Highly Growing Market in Global Industry With Healthy …
The Telomerase Reverse Transcriptase Market report provides detailed profile assessments and current scenario revenue projections for the most promising industry participants. The Global Telomerase Reverse Transcriptase Industry report focuses on the latest trends in the Global and regional spaces on all the significant components, including the capacity, cost, price, technology, supplies, production, profit, and competition. Get Exclusive Sample of Report on Telomerase Reverse Transcriptase market having 114 pages, profiling more
Future Of Telomerase Reverse Transcriptase Market Recent Industry Activity Focus …
Up Market Research offers a latest published report on “Global Telomerase Reverse Transcriptase Market Research Report 2019” delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 105 pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability. Request Sample Copy Of this Report @ https://www.upmarketresearch.com/home/requested_sample/63970 Telomerase Reverse Transcriptase Market research report delivers a close
Global Telomerase Reverse Transcriptase Market 2018 - Argos Therapeutics Inc, e- …
Eminent Market, recently published a detailed market research study focused on the “Global Telomerase Reverse Transcriptase Market Status By Manufacturers, Types And Application, History And Forecast 2025 Market” across the global, regional and country level. The report provides 360° analysis of “Global Telomerase Reverse Transcriptase Market Status By Manufacturers, Types And Application, History And Forecast 2025 Market” from view of manufacturers, regions, product types and end industries. The global Telomerase
Telomerase Reverse Transcriptase Market to Witness Excellent Long-Term Growth Ou …
Qyresearchreports include new market research report Telomerase Reverse Transcriptase to its huge collection of research reports. The global Telomerase Reverse Transcriptase market will be extensively covered in our latest report, which mainly outlines key occurrences in the market. Product launches, advancements in technology, and collaborations within businesses are some of these events, which are exhaustively covered in the report. The study has been carried out based on qualitative as well as
Global Telomerase Reverse Transcriptase Market Forecast 2018-2025 Argos Therapeu …
A comprehensive market study on "Global Telomerase Reverse Transcriptase Market 2018-2025" examines the performance of the Telomerase Reverse Transcriptase market. It encloses an in-depth Research of the Telomerase Reverse Transcriptase market state and the competitive landscape globally. This report analyzes the potential of Telomerase Reverse Transcriptase market in the present and the future prospects from various angles in detail. Leading Manufacturers Analysis such as - Argos Therapeutics Inc, Asterias Biotherapeutics Inc,
Global Telomerase Reverse Transcriptase Market 2017 - Invectys SA, Telocyte LLC, …
Apex Market Reports, recently published a detailed market research study focused on the "Telomerase Reverse Transcriptase Market" across the global, regional and country level. The report provides 360° analysis of "Telomerase Reverse Transcriptase Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Telomerase Reverse Transcriptase industry, and estimates the future trend of